SidSal partners with Boehringer Ingelheim

The Algerian Sidal Complex has signed a cooperation agreement with the German company Boehringer Ingelheim aimed at localizing the manufacturing and production of an innovative treatment for pulmonary fibrosis in Algeria. Production will take place at the Harrach facilities using the latest technologies, promoting knowledge transfer and developing national expertise. This initiative represents an important step towards strengthening the domestic pharmaceutical industry and reducing reliance on imports, while opening up prospects for future exports.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article